Literature DB >> 24859595

Changing patterns of antimicrobial susceptibility of invasive pneumococcal diseases after introduction of pneumococcal conjugate vaccine.

Nuri Bayram1, Hurşit Apa, Gamze Gülfidan, Ilker Günay, Nurettin Ünal, Ilker Devrim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859595     DOI: 10.1007/s12098-014-1485-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

1.  Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004.

Authors:  Isik Yalçin; Nezahat Gürler; Emre Alhan; Akgün Yaman; Mehmet Turgut; Umit Celik; Necla Akçakaya; Yildiz Camcioğlu; Sukufe Diren; Bülent Yildirim
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

Review 2.  13-valent pneumococcal conjugate vaccine (PCV13).

Authors:  Johanna M C Jefferies; Emily Macdonald; Saul N Faust; Stuart C Clarke
Journal:  Hum Vaccin       Date:  2011-10-01

3.  Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-05-12       Impact factor: 17.586

4.  Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide.

Authors:  Mehmet Ceyhan; Nezahat Gurler; Akgun Yaman; Candan Ozturk; Lutfiye Oksuz; Sengul Ozkan; Melike Keser; Nuran Salman; Emre Alhan; Duygu Esel; Meral Gultekin; Yildiz Camcioglu; Mustafa Gul; Yelda Sorguc; Sohret Aydemir; Murat Gunaydin; Yusuf Yakupogullari; Ahmet Kizirgil
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 5.  Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.

Authors:  Daniel J Isaacman; E David McIntosh; Ralf R Reinert
Journal:  Int J Infect Dis       Date:  2009-08-22       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.